Michael Kaseta

Michael Kaseta

Director of Finance/CFO at LIQUIDIA CORPORATION

Net worth: 8 M $ as of 2026-05-30

50 year
Health Technology
Consumer Services

Profile

Michael Kaseta is currently Director at Bryn Pharma LLC since 2023, Independent Director at Heron Therapeutics, Inc. since 2024, Chief Financial & Operating Officer at Liquidia Corp.
since 2020, and Chief Financial & Operating Officer at Liquidia Technologies, Inc. since 2020.
Former roles include Independent Director at Alimera Sciences, Inc. from 2023 to 2024, Chief Financial Officer-Sanofi North America at Sanofi from 2015 to 2016, Chief Financial Officer at Aerami Therapeutics, Inc. from 2019 to 2020, and Chief Financial & Accounting Officer at Old API Wind-down Ltd. from 2018 to 2019.
Education includes undergraduate studies at James Madison University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-22 130,442 ( 0.15% ) 8 M $ 2026-05-30
2026-04-13 29,787 ( 0.02% ) 25 915 $ 2026-05-30

Michael Kaseta active positions

CompaniesPositionStart
LIQUIDIA CORPORATION Director of Finance/CFO 2020-11-29
HERON THERAPEUTICS, INC. Director/Board Member 2024-11-03
Director/Board Member 2023-05-01
Director of Finance/CFO 2020-08-19

Former positions of Michael Kaseta

CompaniesPositionEnd
ALIMERA SCIENCES, INC. Director/Board Member 2024-09-15
Director of Finance/CFO 2020-10-31
OLD API WIND-DOWN LTD. Director of Finance/CFO 2018-12-31
SANOFI Corporate Officer/Principal 2016-08-31
See the detail of Michael Kaseta's experience

Training of Michael Kaseta

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Kaseta